AegirBio AB (AegirBio AB) Total Equity : $-1.01 Mil (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is AegirBio AB Total Equity?

AegirBio AB's total equity for the quarter that ended in Mar. 2024 was $-1.01 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

AegirBio AB Total Equity Historical Data

The historical data trend for AegirBio AB's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AegirBio AB Total Equity Chart

AegirBio AB Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Total Equity

0.09

4.65

40.75

3.84

-0.14

AegirBio AB Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Equity	Get a 7-Day Free Trial													8.62	2.37	0.68	-0.14	-1.01

AegirBio AB Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

AegirBio AB's Total Equity for the fiscal year that ended in Dec. 2023 is calculated as

Total Equity	=	Total Assets(Q: Dec. 2023 )	-	Total Liabilities(Q: Dec. 2023 )
	=	5.177	-	5.318
	=	-0.14

AegirBio AB's Total Equity for the quarter that ended in Mar. 2024 is calculated as

Total Equity	=	Total Assets(Q: Mar. 2024 )	-	Total Liabilities(Q: Mar. 2024 )
	=	4.797	-	5.809
	=	-1.01

AegirBio AB Total Equity Related Terms

Thank you for viewing the detailed overview of AegirBio AB's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

AegirBio AB (AegirBio AB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » AegirBio AB (GREY:AEGBF) » Definitions » Total Equity

Comparable Companies

Traded in Other Exchanges

AEGIR:Sweden 52Q:Germany

Address

Scheelevagen 27, Lund, SWE, SE-223 63

Website

https://www.aegirbio.com

AegirBio AB is a Swedish diagnostic company that offers tests to monitor and optimize the dosage of biological drugs via its patented technology platform. The company's products include Monator - drug monitoring of tysabri in MS, Veritope, and Magniareader.

AegirBio AB (AegirBio AB) Headlines

No Headlines